ARTICLE | Clinical News
JNJ-4178: Ph IIb OMEGA-1 started
December 30, 2016 1:42 AM UTC
Achillion said Johnson & Johnson began the open-label, international Phase IIb OMEGA-1 trial to evaluate oral JNJ-4178 once daily for 6 or 8 weeks in about 300 patients without cirrhosis. JNJ-4178 com...